Immunotherapy in Advanced Hodgkin Lymphoma
Patients who received Opdivo and chemotherapy had better outcomes and fewer side effects than those who had the standard-of-care therapy.
Progress Against Cancer
Patients who received Opdivo and chemotherapy had better outcomes and fewer side effects than those who had the standard-of-care therapy.
An experimental antibody helped people recover body mass lost due to cancer and treatment.
Shorter, more intense radiation regimens may be as effective as traditional treatments, with greater convenience for patients.
People with metastatic hormone receptor-positive breast cancer are living longer, thanks to new targeted therapies and endocrine therapies that can be prescribed when treatment resistance develops.
Blood tests can guide treatment choices, delivering results in less time than traditional biopsies.
This month, the editors of AACR's journals tout studies showcasing the immunostimulatory impact of senescent cancer cells, a novel bispecific immunotherapy, and more.
A promising new personalized vaccine headlines several recent breakthroughs that highlight progress in kidney cancer research.
Multiple myeloma can be tricky to treat, but many treatment options exist, and new research is constantly supporting more.
Cancer screenings are key to saving lives. Take colonoscopies, for example, which are estimated to reduce colorectal cancer risk by about 30%. This is because undergoing colonoscopies as recommended (every 10 years beginning at...
Men with metastatic prostate cancer urged to ask questions about care, and early-phase study suggests benefit of pancreatic cancer vaccine.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More